BACKGROUND AND PURPOSE: EPM1, caused by mutations in the CSTB gene, is the most common form of PME. The most incapacitating symptom of EPM1 is action-activated and stimulus-sensitive myoclonus. The clinical severity of the disease varies considerably among patients, but so far, no correlations have been observed between quantitative structural changes in the brain and clinical parameters such as duration of the disease, age at onset, or myoclonus severity. The aim of this study was to evaluate possible changes in CTH of patients with EPM1 compared with healthy controls and to correlate those changes with clinical parameters. MATERIALS AND METHODS: Fifty-three genetically verified patients with EPM1 and 70 healthy volunteers matched for age and sex underwent 1.5T MR imaging. T1-weighted 3D images were analyzed with CTH analysis to detect alterations. The patients were clinically evaluated for myoclonus severity by using the UMRS. Higher UMRS scores indicate more severe myoclonus. RESULTS: CTH analysis revealed significant thinning of the sensorimotor and visual and auditory cortices of patients with EPM1 compared with healthy controls. CTH was reduced with increasing age in both groups, but in patients, the changes were confined specifically to the aforementioned areas, while in controls, the changes were more diffuse. Duration of the disease and the severity of myoclonus correlated negatively with CTH. CONCLUSIONS: Cortical thinning in the sensorimotor areas in EPM1 correlated significantly with the degree of the severity of the myoclonus and is most likely related to the widespread stimulus sensitivity in EPM1.
BACKGROUND AND PURPOSE:EPM1, caused by mutations in the CSTB gene, is the most common form of PME. The most incapacitating symptom of EPM1 is action-activated and stimulus-sensitive myoclonus. The clinical severity of the disease varies considerably among patients, but so far, no correlations have been observed between quantitative structural changes in the brain and clinical parameters such as duration of the disease, age at onset, or myoclonus severity. The aim of this study was to evaluate possible changes in CTH of patients with EPM1 compared with healthy controls and to correlate those changes with clinical parameters. MATERIALS AND METHODS: Fifty-three genetically verified patients with EPM1 and 70 healthy volunteers matched for age and sex underwent 1.5T MR imaging. T1-weighted 3D images were analyzed with CTH analysis to detect alterations. The patients were clinically evaluated for myoclonus severity by using the UMRS. Higher UMRS scores indicate more severe myoclonus. RESULTS:CTH analysis revealed significant thinning of the sensorimotor and visual and auditory cortices of patients with EPM1 compared with healthy controls. CTH was reduced with increasing age in both groups, but in patients, the changes were confined specifically to the aforementioned areas, while in controls, the changes were more diffuse. Duration of the disease and the severity of myoclonus correlated negatively with CTH. CONCLUSIONS: Cortical thinning in the sensorimotor areas in EPM1 correlated significantly with the degree of the severity of the myoclonus and is most likely related to the widespread stimulus sensitivity in EPM1.
Authors: David H Salat; Randy L Buckner; Abraham Z Snyder; Douglas N Greve; Rahul S R Desikan; Evelina Busa; John C Morris; Anders M Dale; Bruce Fischl Journal: Cereb Cortex Date: 2004-03-28 Impact factor: 5.357
Authors: L A Pennacchio; A E Lehesjoki; N E Stone; V L Willour; K Virtaneva; J Miao; E D'Amato; L Ramirez; M Faham; M Koskiniemi; J A Warrington; R Norio; A de la Chapelle; D R Cox; R M Myers Journal: Science Date: 1996-03-22 Impact factor: 47.728
Authors: Boris C Bernhardt; Keith J Worsley; Pierre Besson; Luis Concha; Jason P Lerch; Alan C Evans; Neda Bernasconi Journal: Neuroimage Date: 2008-05-11 Impact factor: 6.556
Authors: Inken Körber; Shintaro Katayama; Elisabet Einarsdottir; Kaarel Krjutškov; Paula Hakala; Juha Kere; Anna-Elina Lehesjoki; Tarja Joensuu Journal: PLoS One Date: 2016-06-29 Impact factor: 3.240
Authors: Otto Manninen; Tero Puolakkainen; Jemina Lehto; Elina Harittu; Aki Kallonen; Marko Peura; Tiina Laitala-Leinonen; Outi Kopra; Riku Kiviranta; Anna-Elina Lehesjoki Journal: Bone Rep Date: 2015-11-06